Invesco’s Aravive, Inc. Common Stock ARAV Stock Holding History

Invesco’s Portfolio ARAV Stock Details ARAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-11,502	Closed	-$76K	–	4057
2021 Q1	$76K	Buy	11,502 +333	+3%	+$2.19K	﹤0.01%	3795
2020 Q4	$63K	Buy	+11,169	New	+$61.3K	﹤0.01%	3713
2020 Q3	–	Sell	-14,717	Closed	-$171K	–	3706
2020 Q2	$171K	Sell	14,717 -1,983	-12%	-$23.5K	﹤0.01%	3513
2020 Q1	$96K	Buy	+16,700	New	+$150K	﹤0.01%	3572
2018 Q3	–	Sell	-1,685	Closed	-$20K	–	3935
2018 Q2	$20K	Buy	+1,685	New	+$17.4K	﹤0.01%	3836
2018 Q1	–	Sell	-18,208	Closed	-$240K	–	3783
2017 Q4	$240K	Buy	+18,208	New	+$234K	﹤0.01%	3499
2017 Q3	–	Sell	-6,137	Closed	-$643K	–	3677
2017 Q2	$643K	Buy	+6,137	New	+$659K	﹤0.01%	3235
2015 Q3	–	Sell	-55	Closed	-$5K	–	4038
2015 Q2	$5K	Buy	+55	New	+$5.57K	﹤0.01%	4231

Other funds holding ARAV

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco's ARAV Position: Q2 2021 in Review

Invesco sold out of Aravive, Inc. Common Stock (ARAV) in Q2 2021, closing a stake of 11,502 shares — an estimated $76K sold.

Invesco first reported a position in ARAV in Q2 2015 and held it in 8 quarters. The position peaked at $643K in Q2 2017. 49 funds tracked by Wall St. Rank hold ARAV as of Q2 2021.

Invesco reported no remaining Aravive, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Invesco sold 11,502 Aravive, Inc. Common Stock shares in Q2 2021, an estimated $76K.
Invesco first reported a position in Aravive, Inc. Common Stock in Q2 2015 and held it in 8 quarters.
Invesco's Aravive, Inc. Common Stock position peaked at $643K in Q2 2017.
49 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q2 2021.

Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.